Article

A Narrative Review on Adverse Effects of Dasatinib With a Focus on Pharmacotherapy of Dasatinib-Induced Pulmonary Toxicities

2021-03-22

Abstract excerpt

Chronic myeloid leukemia (CML), a myeloproliferative disorder, is caused by overactivity of BCR-ABL1 (breakpoint cluster region-Abelson) has been successfully treated by Tyrosine kinase inhibitors (TKIs). While imatinib is known as the first-line treatment of CML, in some cases other TKIs including dasatinib, nilotinib, bosutinib, and ponatinib may be preferred. Dasatinib, a second-generation TKI, inhibits multipl...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 298cea40-eb88-53e4-ac2d-0171b1ec9c81
DOI: 10.22541/au.161641901.15254184/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A Narrative Review on Adverse Effects of Dasatinib With a Focus on Pharmacotherapy of Dasatinib-Induced Pulmonary ToxicitiesDOI 10.22541/au.161641901.15254184/v1Read

The development of dasatinib as a treatment for chronic myeloid leukemia (CML): from initial studies to application in newly diagnosed patients.Semantic proximity Read

Dasatinib treatment for Philadelphia chromosome‐positive leukemiasSemantic proximity Read

Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial.Semantic proximity Read

Ponatinib in the Treatment of Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Leukemia: Recommendations of a German Expert Consensus Panel with Focus on Cardiovascular ManagementSemantic proximity Read

Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension.Semantic proximity Read

SEVERE HEMORRHAGIC COLITIS CAUSED BY DASATINIB IN PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIASemantic proximity Read

Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.Semantic proximity Read

DasatinibSemantic proximity Read

Dasatinib for the treatment of chronic myeloid leukemia: patient selection and special considerations.Semantic proximity Read

Dasatinib induces notable hematologic and cytogenetic responses in chronic-phase chronic myeloid leukemia after failure of imatinib therapy.Semantic proximity Read

Ponatinib in the therapy of chronic myeloid leukemia.Semantic proximity Read

Resistant mutations in CML and Ph+ALL &ndash; role of ponatinibSemantic proximity Read